The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE

Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) is a common and severe disease with a considerable social and economic impact. So far, the etiology is not known, and neither a diagnostic marker nor licensed treatments are available yet. The EUROMENE network of European researchers and clinicians aims to promote cooperation and advance research on ME/CFS. To improve diagnosis and facilitate the analysis of clinical trials surrogate markers are urgently needed. As a first step for developing such biomarkers for clinical use a database of active biomarker research in Europe was established called the ME/CFS EUROMENE Biomarker Landscape project and the results are presented in this review. Further we suggest strategies to improve biomarker development and encourage researchers to take these into consideration for designing and reporting biomarker studies.

• Publication year

  2017

• Venue

  Journal of Translational Medicine

• Publication date

  2017-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s12967-017-1263-zPMID 28747192PMCID 5530475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

  2017cited by this paper
• How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies?

  2017cited by this paper
• Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles

  2016cited by this paper
• Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.

  2016cited by this paper
• Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.

  2016cited by this paper
• Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

  2016cited by this paper
• Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross‐sectional study

  2016cited by this paper
• Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome

  2016cited by this paper
• MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)

  2016cited by this paper
• Metabolic features of chronic fatigue syndrome

  2016cited by this paper
• Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients

  2016cited by this paper
• Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome

  2016cited by this paper
• Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity.

  2016cited by this paper
• Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome

  2016cited by this paper
• Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study

  2016cited by this paper
• Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome

  2015cited by this paper
• Plasma cytokine expression in adolescent chronic fatigue syndrome.

  2015cited by this paper
• Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.

  2015cited by this paper
• Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome

  2015cited by this paper
• B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

  2015cited by this paper
• Chronic fatigue syndrome and circulating cytokines: A systematic review.

  2015cited by this paper
• Increased prevalence of two mitochondrial DNA polymorphisms in functional disease: Are we describing different parts of an energy-depleted elephant?

  2015cited by this paper
• Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis Hypofunction and Childhood Trauma

  2015cited by this paper
• Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.

  2015cited by this paper
• In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.

  2015cited by this paper
• Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome

  2014cited by this paper
• Dimensions of pure chronic fatigue: psychophysical, cognitive and biological correlates in the chronic fatigue syndrome

  2014cited by this paper
• The role of hypocortisolism in chronic fatigue syndrome.

  2014cited by this paper
• No evidence of XMRV provirus sequences in patients with myalgic encephalomyelitis/chronic fatigue syndrome and individuals with unspecified encephalopathy.

  2014cited by this paper
• Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome

  2014cited by this paper
• A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers

  2013cited by this paper
• Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls

  2013cited by this paper
• Xenobiotic Sensor- and Metabolism-Related Gene Variants in Environmental Sensitivity-Related Illnesses: A Survey on the Italian Population

  2013cited by this paper
• Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome.

  2013cited by this paper
• Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation☆

  2013cited by this paper
• Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

  2013cited by this paper
• Could Mitochondrial Dysfunction Be a Differentiating Marker Between Chronic Fatigue Syndrome and Fibromyalgia?

  2013cited by this paper
• Lack of evidence for retroviral infections formerly related to chronic fatigue in Spanish Fibromyalgia patients

  2013cited by this paper
• Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

  2013cited by this paper
• Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis

  2013cited by this paper
• Absence of Xenotropic Murine Leukemia Virus-Related Virus in Italian Patients Affected by Chronic Fatigue Syndrome, Fibromyalgia, or Rheumatoid Arthritis

  2012cited by this paper
• Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2012cited by this paper
• Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome.

  2012cited by this paper
• Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins

  2012cited by this paper
• Lipid and protein oxidation in female patients with chronic fatigue syndrome

  2012cited by this paper
• Myalgic encephalomyelitis: International Consensus Criteria

  2011cited by this paper
• "Omics" data and levels of evidence for biomarker discovery.

  2009cited by this paper
• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

  2001cited by this paper
• as an health

  1999cited by this paper
• The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study

  1994cited by this paper

• Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Insights into Disease Mechanisms

  2025cites this paper
• Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study

  2025cites this paper
• Myalgic encephalomyelitis/chronic fatigue syndrome from current evidence to new diagnostic perspectives through skeletal muscle and metabolic disturbances

  2024cites this paper
• Development of an ME/CFS Online Screener

  2024cites this paper
• The German Multicenter Registry for ME/CFS (MECFS-R)

  2024cites this paper
• Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study

  2023cites this paper
• The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID

  2023cites this paper
• Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis

  2023cites this paper
• Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2023cites this paper
• Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis

  2022cites this paper
• A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

  2022cites this paper
• Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2022cites this paper
• Impact of imperfect diagnosis in ME/CFS association studies

  2022influential citation
• Editorial: Current Insights Into Complex Post-infection Fatigue Syndromes With Unknown Aetiology: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Beyond

  2022cites this paper
• The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection

  2021cites this paper
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Where Will the Drugs Come From?

  2021cites this paper
• Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany: a first analysis of a prospective observational study

  2021cites this paper
• Our Evolving Understanding of ME/CFS

  2021cites this paper
• Statistical challenges of investigating a disease with a complex diagnosis

  2021cites this paper
• Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2021cites this paper
• The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)

  2021cites this paper
• Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients

  2021cites this paper
• Dysregulation of the Kennedy Pathway and Tricarboxylic Acid Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2021cites this paper
• Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank

  2021influential citation
• Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome

  2021cites this paper
• Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective—In Light of COVID-19

  2021cites this paper
• Environmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome

  2020cites this paper
• An Adrenalectomy Mouse Model Reflecting Clinical Features for Chronic Fatigue Syndrome

  2020cites this paper
• Chronic Fatigue Syndrome (CFS): An Imprecisely Defined Infectious Disease Caused by Stealth Adapted Viruses

  2020cites this paper
• Myalgic encephalomyelitis - enigma at the medicine’s crossroads

  2020cites this paper
• Use of Machine Learning Algorithms to Predict Illness Severity and Diagnosis Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) From Patient Data

  2020cites this paper
• Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS

  2020cites this paper
• Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts

  2020cites this paper
• Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  2020cites this paper
• Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments

  2019cites this paper
• In Search of Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  2019cites this paper
• Advances in ME/CFS: Past, Present, and Future

  2019cites this paper
• A Timely Multidisciplinary Update on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  2019cites this paper
• Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.

  2019cites this paper
• Chronic fatigue syndrome: the ongoing medical debate

  2018cites this paper
• The biopolitics of CFS/ME.

  2018cites this paper
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?

  2018cites this paper
• Old muscle in young body: an aphorism describing the Chronic Fatigue Syndrome

  2018cites this paper
• JTM advances in uncharted territories: diseases and disorders of unknown etiology

  2017cites this paper
• La salive et la santé : des biomarqueurs aux biocapteurs

  2017cites this paper